KeyCorp Operating Cash Flow decreased by 108.6% to -$62.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 55.7%, from -$140.00M to -$62.00M. Over 3 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 23.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $453.00M | $915.00M | $0.00 | $881.00M | $0.00 | $2.08B | $1.59B | $718.00M | $582.00M | $566.00M | $1.04B | $359.00M | -$1.21B | $1.73B | -$140.00M | $1.23B | $396.00M | $718.00M | -$62.00M |
| QoQ Change | — | +102.0% | -100.0% | — | -100.0% | — | -23.8% | -54.7% | -18.9% | -2.7% | +83.2% | -65.4% | -435.7% | +243.3% | -108.1% | +981.4% | -67.9% | +81.3% | -108.6% |
| YoY Change | — | — | — | — | -100.0% | +127.4% | — | -18.5% | — | -72.8% | -34.6% | -50.0% | -312.9% | +66.5% | -139.0% | — | +132.9% | -58.4% | +55.7% |